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Abstract
Melatonin is a hormone synthesized from the amino acid tryptophan produced espe-
cially at night in the pineal gland and helps induce sleep. It is reported to play a role in 
preventing the production of free radicals and is thus a potent antioxidant. It can also 
enhance the function of the immune system and appears to have an antitumor effect. 
Melatonin secretion, mediated by photoperiod, directly influences reproductive function 
and dopamine which moves into frontal lobe regulating flow of information coming in 
from other areas of the brain. Additional side effects may be produced from treatment 
with melatonin and include stomach cramps, dizziness, headache, irritability, breast 
enlargement in men (called gynecomastia), and decreased sperm count. For clinical 
trials, the direct effect of exogenous melatonin administration on patients manifested 
with cancer should be studied to find its oncostatic effects on some cancers and provide 
information on its dosage and long-term safety. Moreover, mechanisms of action should 
be further investigated.
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1. Hormone description
Melatonin is a hormone (N-acetyl-5 methoxytryptamine) produced especially at night in the 
pineal gland which helps in the maintenance of the body’s hormone balance and regulation, in 
immune system integrity, and in circadian rhythm (daily metabolic balance). This gland func-
tions as a biological clock and time keeper of the brain by secreting melatonin and many other 
neuropeptides at night, helps to govern the sleep-wake cycle and, in animals, seasonal rhythms 
© 2018 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
of migration, mating, and hibernation. Secretion of melatonin is stimulated by the dark and 
inhibited by light. Melatonin levels start to be released at sunsets, where neural signals are 
triggered which stimulate the pineal gland to begin releasing the hormone.
Melatonin is synthesized from the amino acid tryptophan. Tryptophan (l-tryptophan) is 
an essential amino acid formed from proteins during digestion by the action of proteolytic 
enzymes. Tryptophan is converted to serotonin, a brain chemical involved with mood during 
the day and the latter finally converted to the indole melatonin (Figures 1 and 2). Melatonin 
occurs naturally in some foods but in fairly small amounts. Of all the plant-based foods, oats, 
sweet corn and rice are the richest source in melatonin, containing between 1000 and 1800 
picograms while ginger, tomatoes, bananas and barley levels amount to 500 picograms per 
gram. In the human population, melatonin levels are highest in children and middle-aged 
adults and usually about 5–25 micrograms of melatonin are secreted each night. This amount 
tends to decline with age, a possible link with an age-related rise in difficulty sleeping and in 
the production of free radicals [1]. Synthetic melatonin and melatonin derived from bovine 
pineal glands are available as dietary supplements over-the-counter.
Figure 2. The biosynthesis and metabolism process of melatonin. www.impactjournals.com/oncotarget.
Figure 1. Chemical structure of Tryptophan (A) and Melatonin (B).
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2. Biological functions
Melatonin, stimulated by darkness and inhibited by light, is involved in synchronizing the 
body’s hormone secretions and in regulating their levels, setting the brain’s internal biological 
clock and hence controlling circadian rhythms (daily biorhythms) or sleep-wake. Melatonin 
regulates many neuroendocrine functions and can inhibit secretion of luteinizing hormone 
(LH) and follicle stimulating hormone (FSH) from the anterior pituitary gland. When the tim-
ing or intensity of melatonin peak is disrupted (as in aging, stress, jet-lag, or artificial jet-lag 
syndromes), the biological clock is upset and many physiological and mental functions are 
adversely affected including the ability to think, remember, and make sound decisions can be 
profoundly hampered. Melatonin is also controls the timing and release of female reproduc-
tive hormones and hence helps determine when menstruation begins and ends (menopause), 
and the frequency and duration of menstrual cycles [1].
In addition to its hormone actions, melatonin also has strong antioxidant properties and may 
scavenge and eliminate cell-damaging free radicals. The latter are chemical constituents that 
have an unpaired electron and cause lipid peroxidation, DNA damage and protein oxidation. 
Besides, it inhibits nitric oxide synthetase enzyme leading to reduction in the formation of 
peroxynitrite in tissues of brain. Melatonin stimulates the activities of antioxidant enzymes; 
glutathione peroxidase, superoxide dismutase and catalase. Melatonin is twice as effective at 
protecting cell membranes from lipid peroxidation as vitamin E and is five times more effec-
tive than glutathione for neutralizing hydroxyl radicals. As an antioxidant, it possibly helps 
to control or delay the development of heart disease, cancer and other conditions and may be 
effective in destroying malignant cells when combined with certain anticancer drugs. Since 
glutathione concentrations are not very high in the brain, both melatonin and adenosine may 
be particularly important in protecting brain cells [1].
3. Melatonin as an activity enhancer of antioxidative enzymes
Two decades ago, melatonin was found to be a free radical scavenger [2]. However, abundant 
data ascertaining its ability to reduce oxidative stress have rapidly accumulated [3, 4]. The 
efficacy of melatonin in functioning in this subject is related to its direct free radical scaveng-
ing actions. Owing to its chemical formula, melatonin can interact with various forms of free 




, •OH, singlet oxygen (1O
2
), superoxide anion (•O
2
−), peroxynitrite anion 
(ONOO−) and peroxyl radical (LOO•) [4]. The main photoproduct metabolites of melatonin 
degradation are potent antioxidants such as N1-acetyl-5-methoxykynuramine (AMK) or N1-
acetyl-N2-formyl-5-methoxykynuramine (AFMK) [4]. Moreover, investigations on free radi-
cals produced as a result of UV exposure, showed that by using cell-free melatonin-containing 
systems exposed to UV radiation (UVB: 60%, UVA: 30%) four metabolites were identified 
by HPLC and LC–MS: 2-OH-melatonin, 4-OH-melatonin, 6-OH-melatonin and AFMK [5]. 
Since these metabolites are potent antioxidants, this may suggest that, unlike other classic 
antioxidants, they do not induce prooxidant reactions. In addition, melatonin acts as a potent 
antioxidant through enhancing activity of antioxidant enzymes [6]. It should be noted that not 
only enzyme activity, but also gene transcription of antioxidant enzymes such as manganese 
Melatonin and Its Indisputable Effects on the Health State
http://dx.doi.org/10.5772/intechopen.79817
89
superoxide dismutase (Mn-SOD), copper-zinc superoxide dismutase (Cu/Zn-SOD), glutathi-
one peroxidase (GPx) and gamma-glutamyl cysteine synthetase (γ-GCS) were maintained by 
melatonin n brain of rat [4]. This continuing enhancement proposed a possible role of activa-
tion of melatonin receptors to modulate antioxidant enzymes regulation following stress sig-
nals [7]. Actually, there are some suggestions that melatonin-modified antioxidant enzymes 
expression following signal pathways of membrane, cytosolic and nuclear receptors [8].
4. The melatoninergic antioxidative system (MAS) of the skin
It should be mentioned that synthesis of melatonin is not only confined to the pineal gland, 
but also extends to various other organs including the skin [4]. After exposure to UV, mel-
atonin is metabolized in the skin and in turn causes production of antioxidant melatonin 
metabolites in human keratinocytes. This antioxidant cascade can be suggested for the skin, 
the same as in several described melatonin-related antioxidant cascades in chemical or other 
tissue homogenate systems [9]. This cascade has been defined as the melatoninergic antioxi-
dative system (MAS) of the skin (Figure 2) forming an important barrier organ and protecting 
it against UV-induced oxidative stress-mediated damaging events on the nuclear, subcel-
lular, protein and cell morphology level [5]. Melatonin forms a defense mechanism against 
the multifaceted threats of environmental stress, especially UV, to which the skin is life-long 
exposed. Owing to its chemical structure, melatonin as well as its metabolites are strongly 
lipophilic, which renders them easily diffusible in every skin and cell compartment, therefore 
penetrating beyond the epidermis, namely to the dermis and the hair follicle [10]. When the 
skin is exposed to UV irradiation, the reactive hydroxyl radical is generated in the skin and 
reacts directly with melatonin [11]. The scavenging effect of melatonin to hydroxyl radicals 
causes decrease in the lipid peroxides, oxidation of protein and damage of mitochondrial 
DNA. Thus, the cascade of melatoninergic antioxidative is significant in decreasing the free 
radicals emerging from radiation of UV and subsequently performs, a very hopeful strategy 
to keep the skin versus stressor factor of environmental condition as well as causative agent 
for aging of skin and promotion of tumor.
5. Anti-aging
Another functional importance of melatonin is its potency to enhance, augment or neutralize 
the negative effects that stress, drugs and infections have on the body’s immune system. The 
decrease in melatonin secretion by age is so reliable that blood melatonin levels have been 
proposed as a measurement of biological age.
Melatonin is critical for the regulation of circadian and seasonal changes in various aspects of 
physiology and neuroendocrine functions [12]. The reduction in life span was detected in rats 
as a result of a pinealectomy [12], whereas prolongation in the life span occurs upon transfer 
of pineal gland grafting from young mice into thymus of old mice or into pinealectomized 
old mice which reveals the ability of melatonin to extend life span [12]. Analysis of available 
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data on the effect of melatonin on longevity supports its geroprotective effect. We believe that 
melatonin biosafety is important for the study of it’s the long-term effects at different doses 
and in different strains and species (e.g., in rats). In adequately designed work (50 rats in each 
group), small doses of melatonin were supplemented at the night (2.5–3 mg/kg), slow the 
starting of age-associated disorders in function of estrous and elevated the animals survival. 
There are multiple evident on the melatonin suppressive effect on the growth of impulsive 
mammary carcinogenesis and that initiated in mice and rats as a results of chemicals and radi-
ation [13–15], carcinogenesis induced in colon of rats by 1,2-dimethyl hydrazine [16], while, 
carcinogenesis induced in uterine cervix and vagina of mice by DMBA [16] and liver cancer 
induced in rats by N-nitrosodiethylamine [17]. In these cases, it was observed that melatonin 
exerted a positive effect in the treatment of advanced cancer patients [18]. Melatonin has a dual 
effect: it is potent geroprotector, suppressor of tumor growth in vivo and in vitro. There are no 
discrepancies between results of the carcinogenic and anticarcinogenic potential of melatonin 
since previous reports showed that other antioxidants, such as α-tocopherol has geroprotec-
tor and tumorigenic effects and could be powerful anticarcinogens as well. The data of mela-
tonin supplementation to perimenopausal women are hopeful [19]. Simultaneously, there are 
actual results on the unfavorable impacts of melatonin [12] such as melatonin may produce 
infertility, damage of retina and hypothermia, it stimulates high blood pressure, diabetes, and 
cancer by suppressing sex drive in males. It was remark that melatonin may be harmful for 
people with cardiovascular risk factors and it should not be obtain by individuals who have 
immune-system or mental disorders, or by people administered steroids.
6. Melatonin as a protector against UV-induced skin aging
Because of its properties as wide antioxidant and scavenger of free radical, melatonin may act 
as a preventative factor against damage induced by UV in the skin [5]. Clinically melatonin is 
worthy to protect damage of sun when it is taken before irradiation of UV [20]. These effects 
of melatonin as a protective agent versus damage induced by UV have in vitro studies power-
ful support [20, 21]. Melatonin counteracting the formation of polyamine levels so it enhances 
cell viability in UV-irradiated fibroblasts, and malondialdehyde accumulation while inhibited 
apoptosis cells [21].
Regarding to Ryoo et al. [22] study in fibroblasts exposed to UV, only 56% of the cells sur-
vived (140 mJ/cm2), while the survival rate of cells reached to 92.50% when preincubated with 
1 nM melatonin which was paralleled with marked decrease in malondialdehyde and death 
of cells. Other experimental comparative study using fibroblasts treated by UV declared iden-
tical correlation in viability of cells using 100 nM melatonin [21]. Additionally, melatonin 
is considered as a powerful anti-apoptotic compound that inhibited caspase 9 and caspase 
3 by suppresses mitochondria-dependent (intrinsic) apoptosis however, it does not inhibit 
receptor-dependent (extrinsic) pathway of apoptosis mediated by caspase 8 “[23]. UV irradia-
tion is considered an immediate agent acted directly on skin, the oxidative stress resulting 
in all known successive, destruction events in the skin can distinctly, only be antagonized 
by antioxidants, melatonin which is already found at the target sites and at the same time of 
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exposure to UV ([23]. Besides, there is clear evidence that the preventive actions of melatonin 
against photobiological distraction are ameliorated by the powerful antioxidative characteris-
tic of this compound. Photodamage, is tightly connected with UV-induced generation of ROS 
and it was shown that melatonin is a markedly powerful free radicals scavenger compared 
with vitamin C or Trolox, a vitamin E analog [21].
7. Anti-cancer, immunity and reproduction
Tumor growth is showed to be inhibited by melatonin. Melatonin may be of a great value 
in patients with untreatable metastatic cancer, especially in ameliorating their life quality. 
Several experiments showed that the levels of melatonin may be connected with risk of breast 
cancer. Some chemotherapy drugs used to treat breast cancer may be enhanced also by mela-
tonin. Supplementation of melatonin reduces luteinizing hormone concentrations leading to 
inhibition of ovulation in humans. Further, melatonin administration may aid menopausal 
women by eliciting and sustaining sleep. Levels of melatonin may have a role in the anorexia 
symptoms. It was found that melatonin was used in seasonal affective disorder (SAD), due 
to the disorder is considered to be produced by melatonin release at an inadequate time [1].
Melatonin immunopharmacological activity has been indicated in different models. Melatonin 
treatment elevates antibodies production of sheep erythrocytes and immune response to pri-
mary immunization with T-dependent antigens [24]. Melatonin is involved in complicated 
relationships between the endocrine and nervous systems [25]. There are membrane receptors 
of melatonin on helper (Th). Melatonin receptors activation results to an elevate the produc-
tion of Th1 cytokines, such as γ-interferon, interleukin-1, and opioid cytokines (interleukin-4 
and dinorphine) [25]. At physiological concentrations of melatonin, it induces release of inter-
leukins-1, -6 and -12 in monocytes of human. These mediators can protect stress-stimulated 
immunodepression maintaining mice from virus- and bacteria caused lethal diseases [25]. It is 
useful noticing that γ-interferon and colony-inducing factors (CSFs) can stimulate melatonin 
release in the pineal gland [25].
It is well accepted that melatonin is considered not only a hormone, but also protector for cells 
[26], implicated in modulation of immune system, processes of antioxidant and hematopoiesis 
[27]. Moreover, melatonin has a powerful oncostatic characters, through receptor-dependent 
and -independent mechanisms [28]. The melatonin receptors MT1 (encoded by MTNR1A) 
and MT2 (encoded by MTNR1B) are associated with the G-protein-coupled receptor (GPCR) 
group [26], and are mainly responsible for mediating melatonin downstream effects [29]. 
The antiproliferative effects melatonin may be due to melatonin–stimulated suppression in 
the uptake of linoleic acid [26]. Melatonin also demonstrated the probability to be used as 
adjuvant in therapies of cancer, through augmentation the effects of therapeutic drugs and 
decreased chemotherapies or radiation side effects [26].
Some studies recommended an inverse association between circadian melatonin level 
and breast cancer incidence. In addition, it was demonstrated high melatonin level up to 
≤39.5 pg/mL in female showed high risk for breast cancer than females had high melatonin 
level > 39.5 pg/mL in a case–control study. Besides, in another five prospective case control, 
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an inverse relationship was demonstrated between risk of breast cancer and the highest levels 
of aMT6s in urine [30, 31]. In controversy, in case–control study declared that high aMT6s 
level in urine level was markedly linked with a low breast cancer risk [26]. However, it was 
demonstrated that, no confirmation was detected between level of melatonin and its associa-
tion with risk of breast cancer in four case–control studies. Regardless of menopausal status, 
there is no statistically significant differences was detected in urinary aMT6s level between 
British women with breast cancer and healthy one in a prospective nested case–control [26]. 
In postmenopausal women, there was no suggestion that high melatonin levels in urine were 
inversely associated with risk of breast cancer [32]. In the study of Brown et al. [33], did not 
document an overall correlation between melatonin levels in urine and the onset risk of breast 
cancer [33]. Simultaneously, no markedly relation was detected between level of aMT6s and 
risk of breast cancer (either totally or by status of menopausal) [34].
In other types of cancer, it was found that, the men with low level of aMT6s in the urine below 
the median first morning connected with a four time increase in risk of in comparison with 
those with levels above the median. In addition, a case–control study showed that patients 
with high melatonin-sulfate levels or a high melatonin-sulfate/cortisol ratio were less likely 
to have prostate cancer or advanced stage prostate. It was found that the serum melatonin 
levels in women with ovarian cancer were significantly lower compared with control subjects 
(p < 0.05), demonstrating that decline in circulating melatonin level might contribute to the 
pathogenesis of ovarian cancer in a retrospective study [35].
It is worth mentioning that, the assessment melatonin levels are not equals, since concen-
trations of melatonin were determined in various sample as urine, plasma or serum. Also, 
the concentration of melatonin in human modifies with circadian rhythm; however, it has 
not been demonstrated which the best time for the sample collection could demonstrate the 
effects of melatonin. These variations might incorporate in the discrepancy of researches.
Research relating melatonin’s effects on breast cancer is the serious, may be due to that mela-
tonin has reported to attenuate various endocrine physiological biomarkers. Novel works 
showed that melatonin exhibited antiproliferative action against in vitro cell line of breast 
cancer [26], and suppressed mammary tumors development in rats [26]. Several melatonin 
mechanisms as anticancer were identified as it is apoptosis inducer [36], antiestrogenic effect 
through signaling pathway of ERα and decreased activity of aromatase enzyme [36], attenua-
tion of receptors of melatonin [26], suppression on invasion [37] and angiogenesis [38].
Prostate cancer is the second most cancer type recorded and the fifth leading cause of cancer 
mortality in men [26]. It was found that melatonin at pharmacological concentrations could 
inhibit cell growth of both androgen-dependent and androgen-independent prostate cancer 
[26], through a range of mechanisms.
One of the leading causes of death among women with genital tract disorders is ovarian 
cancer [39]. Even though various surgical techniques and chemotherapies have been useful 
for treatment of ovarian carcinoma, the prognosis remains lacking [40]. In recent years, a few 
studies have reported the anticancer effect of melatonin on cancer of ovary.
Cervical cancer is considered the principle leading reason of female tumor worldwide, [41]. 
The melatonin effect on cervical cancer has been detected in insufficient works.
Melatonin and Its Indisputable Effects on the Health State
http://dx.doi.org/10.5772/intechopen.79817
93
Visceral obesity is a risk factor of endometrial cancer, as it is associated with chronic inflamma-
tory process [42]. Ciortea et al. [42] reported that the combinational treatment of melatonin and 
estrogen in ovariectomized rats was linked with lower body weight, less intra-retroperitoneal 
fat, reduction in endometrial proliferation, and less appearance of cellular atypia compared 
with estrogen replacement treatment. These results show that melatonin supplementation 
could be used in the prophylaxis of endometrial cancer in menopause women [42].
8. Oral cancer
Oral cancer is a common type of human head and neck cancers, and the majority of the cases 
involve oral squamous cell carcinoma [26]. In several in vitro studies, melatonin has shown 
remarkable effect on oral cancer.
It was reported that melatonin presented effect on oral cancer cell lines as an anti-metastatic 
action (HSC-3 and OECM-1), through modulation of expression and activity of MMP-9, which 
was occurred by decreasing acetylation of histone [26]. Also, melatonin could minimize SCC9 
and SCC25 cell lines viabilities (both tongue carcinoma), and exhibit suppressive effect on the 
pro-metastatic ROCK- 1gene expression and HIF-1α pro-angiogenic genes as well as VEGF 
in SCC9 cell line [43]. Overall, inhibitory effect of melatonin was demonstrated on some oral 
cancer cells, and its mechanisms of action mainly involved inhibitory effect on metastasis and 
its related angiogenesis.
Cancer of liver is considered the common reason of death globally, and hepatocellular 
carcinoma (HCC) is contributed to the most common type of cancer (70–80%), occurrence 
in developing countries [44]. Treatment with surgery still remains the most pronounced 
way for HCC patients, however it is only occurs in a few cases, thus it is necessary to find 
efficient chemotherapeutic drug [45]. Hence, several studies pointed out to the effects of 
melatonin on hepatocellular carcinoma. Melatonin modulates the changes produced by 
N-nitrosodiethylamine-initiated cancer of liver and ameliorates biomarkers of liver enzymes 
(ALT, AST), levels of antioxidant, as well as the disturbance in circadian clock in mice [46, 47].
SO, melatonin exerts its anti-liver cancer effects mainly due to its anti- pro-apoptotic activity 
(via COX-2/PI3K/AKT pathway attenuation, modulates the ratio of Bcl-2/Bax, as well as it 
activates ER stress), anti-angiogenesis and anti-invasive effects.
Renal cancer is considered the third high cancer accounts for 3% with predominance of a male 
(3 male/1 female) [26].
Lung cancer is a principal cause of cancer-related death. For instance, lung cancer is the sec-
ond most frequent type of cancer in males with approximately 17,330 new cases identified in 
2016 in Brazil [26]. Non-small-cell lung cancer (NSCLC) is a main form of cancer of lung [26], 
and the literatures have suggested that the disturbance of rhythm of melatonin could elevate 
the incidence of NSCLC [26]. In different researches, melatonin due to mainly because mela-
tonin showed to enhance the effects of it enhances radiotherapy and chemotherapeutic drugs.
Gastric cancer causes a mortality rate ranking second among malignant tumors worldwide 
one of the most frequent forms of cancer worldwide [26]. It was recorded that there were 
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951,600 new cases and 723,100 deaths from gastric cancer in 2012 worldwide [26]. Melatonin 
has been reported to inhibit gastric cancer through various mechanisms in numerous studies.
Pancreatic cancer is a highly fatal disease with a relatively low 5-year survival rate [48]. It 
responds poorly to radiotherapy and chemotherapy because the tumor cells are challenging 
to apoptosis [49].
Colorectal cancer is one of the major causes responsible for cancer death worldwide [26], 
and in several studies, melatonin recorded anticancer potency for various colorectal cancers. 
Overall, melatonin could be a new tempting therapeutic strategy for colorectal cancer, since it 
could regulate carcinogenesis, development, and progression of colorectal cancer. The under-
lying mechanisms involve multiple signaling pathways, including regulation of Ca MKII, 
ET-1, Nrf2 signaling pathways, and induction of aberrant crypt foci (ACF).
9. Effect of melatonin on gene expression
The presenting results on the melatonin genomic effect is rather few. In a study of cytogenecity, 
it was found that a decrease in the gene activity of ribosomes as a result of a pinealectomy in 
rats [12]. Menendez-Pelaez et al. [50] declared that melatonin treatment reduces mRNA level 
in the synthesis porphyrin, and 5- aminolevulinate synthase, in the Syrian hamsters Harderian 
glands. Melatonin declines mRNA levels of histone H4 and stopped age-attributed mRNA 
Bcl-2 reduction, in mice thymocytes [12]. Also, melatonin elevated some antioxidant enzymes 
mRNA (Mn-SOD, Cu,Zn-SOD) in Syrian hamsters Harderian gland [12]. Supplementation of 
melatonin produced significant enhancement in relative levels of mRNA for Mn-SOD, Cu,Zn-
SOD and glutathione peroxidase in cerebral cortexes of rat [12]. Melatonin (1 nM) markedly 
modulates the mRNA of gonadotropin-releasing hormone. It was observed that melatonin 
regulate transforming growth factor-α gene expression level, macrophage-colony stimulating 
factor (M-CSF), tumor necrosis factor-α (TNFα) the stem cell factor in PEC, and interleukin-
1β, M-CSF, TNFα, interferon-γ, and the stem cell factor in splenocytes [12]. These results are 
appropriate with results that the SCN is the main site for the exogenous melatonin effect on 
the amplitude rhythm of the endogenous melatonin [51]. Medication with melatonin sup-
pressed the development of mammary tumor and regulated HER-2/neu onco gene in trans-
genic HER-2/neu mice [52].
Marked melatonin effect was noticed on some oncogenesis- associated genes expression [12]. 
Further, myeloblastosis oncogene-like 1 (Mybl1) expression was adjusted by melatonin. On 
the other hand, melatonin showed a great effect on a large number of genes attributed to 
exchange of calcium, as cullins, Kcnn4 and Dcamkl1, calmodulin, calbindin, Kcnn2 and Kcnn4. 
Meanwhile, cullin-1 expression in the heart of mouse is down regulated, that of cullin-5 is 
significantly upregulated, and cullins-2 and -3 expression are significantly not deformed. Six 
members of cullin family are included, and are implicated in ubiquinone-mediated protein 
destruction necessary for cell-cycle through the G1 and S phases. Nevertheless, cullin-1, but 
not other members of the cullin family, is responsible for cell proliferation and differentia-
tion [53]. It is believe that melatonin may effect on expansion of tumor by intermediating 
with binding of calcium and preventing the MAPs/calmodulin and tubulin/calmodulin com-
plexes formation to stop degradation of cytoskeletal [54]. Peutz-Jeghers syndrome, which is 
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associated with high risk of tumor development in multiple localizations is associated with 
at least one of these, Stk11 kinase with an unclear function, has anticarcinogenic effects and 
mutations [55]. Eventually, these data present undeviating evidence for the different effect of 
melatonin on the expression of different genes in vivo. Specific gene expression profiles are 
connected with the aging process in animals and humans [12]. Lund et al. [56] have detected 
a reduction in gene expression of heat shock protein while an elevation in the insulin-like 
genes expression, resulting in a decline in gene expression of insulin signaling during aging. 
Pletscher et al. [57], showed that down regulation of a large number of genes implicated in 
cell growth and maintenance following caloric restriction. Weindruch et al. [58], declared that 
in mice, the process of aging is describe by the high level of reactive oxygen species in both 
the skeletal muscle and brain, inhibition in the genes expression of biosynthetic enzyme and 
genes implicated in turnover of protein. Hence, caloric restriction stimulated genes are impli-
cated in the metabolism of fatty acid, glycolysis, and gluconeogenesis. Presented results on 
the melatonin effects on gene expression, mainly genes of mitochondria, suggest that some of 
them may be accountable for the hormone capacity to block disorders resulting from aging. 
Further studies are need in this direction.
10. Melatonin and reproduction
Pattern of melatonin secretion, mediated by photoperiod, directly affect reproductive func-
tion which was recorded in several evidence-based researches. The daily light/dark (LD) 
cycle is considered the main physiological melatonin role, so, the variation in the duration 
of signal of melatonin occurs in attribution to the night length. The variation in melatonin 
signal duration is used to synchronize neuroendocrine rhythms with the annual variation in 
day-length in seasonal mammals. In addition, fetal and newborn animals use the maternal 
signal of melatonin to entrain endogenous circadian rhythms before direct photic information 
is presented. It was found that, very marked effect for exogenous melatonin was detected 
in modulating reproductive function in different organisms, depending on the animal age, 
melatonin supplementation time [59].
The data presented above exhibited that the antigonadal effects of melatonin in humans are 
apparently much less significant than in some seasonally breeding mammalian species. This 
is due to humans are not ‘seasonally breeding’. Recently, accumulated evidences declared 
the efficacy of melatonin in attenuation the reproductive function in human. The suppres-
sive effect of melatonin at the level of CNS have decreased daring growth. During develop-
ment of human, such suppressive action of melatonin on GnRH function gradually reduced 
due to a down regulation in the functional of melatonin receptors expression. In other adult 
rodents, melatonin does not have noticeable action on the functioning of pituitary, whereas 
the association between the release of melatonin release and the functions of hypothalamic, 
involving the release of GnRH, are right. These actions are markedly significant in coincid-
ing the external photoperiods and functions of reproduction through well not characterized 
mechanisms. The circadian rhythm regulated genes are considered seriously players in 
regulation of gene throughout different organism, especially for regulatory genes of cell-cycle 
and apoptotic genes. Melatonin may have also ameliorating effectiveness against human dis-
orders attributed to reproductive function. Such as illumination intensity during the night 
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actually decreases circulating levels of melatonin and reconstruct the suprachiasmatic nuclei 
circadian pacemaker, leading to the elevation in risk of breast cancer, which may be due to 
down-regulating gonadal synthesis of steroids, by acting on receptor sites within the neuro-
endocrine reproductive axis or altered estrogen receptor function [59]. Consequently, in the 
right circumstances, melatonin may be quite beneficial for reproductive health.
11. Dopamine and psychosis
Disorder in the system of dopamine has also been noticeably associated with psychosis and 
schizophrenia. Dopamine proceeds in the frontal lobe and regulating the information coming 
in from other parts of the brain. Normalization in the dopamine flow may produce inter-
rupted or discontinuous cogitation as in schizophrenia. Schizophrenia is described by both 
‘positive ‘(additional experience and behavior) and ‘negative symptoms’ (lack in experience 
or behavior). Symptoms of positive response are classifying under the psychosis term and 
identically involve disorders of illusions, deliriums, and intellect. Symptoms of negative 
response may involve unsuitable emotional manifestation, lack of speech and stimulus. Some 
drugs, as cocaine, prevent dopamine return into the brain, coherently, dopamine buildup in 
the synapse, producing drug-initiated psychosis or schizophrenia [1].
12. Contraindications, interactions, precautions and side effects
Melatonin can produce sleepiness if given during the day. Additional, side effects that have 
been documented upon melatonin supplementation including cramps of stomach, vertigo, a 
continuous pain in the head, touchiness, moodiness, reduced sexual desire, enlargement of 
breast in the men and reduction in the count of sperm.
So, melatonin should not take during operating machine or drive. Further, melatonin could 
interrupt with human fertility and also melatonin should be not used for pregnant or nurs-
ing women. Utilization of melatonin by person who already have an augmentation level of 
melatonin as children, teenagers, pregnant and lactating women can result in melatonin over-
dose. MAOI drugs inhibit melatonin breakdown from the body, so people should not take 
melatonin with these drugs to prevent melatonin overdose.
Melatonin causes drug–drug interaction with antidepressants, such as Prozac (inhibitor of 
serotonin) or Nardil (inhibitor of monoamine oxidase). Melatonin Interaction with these 
kinds of drugs can produce heart attack, confusion, sweating, shaking, and fever, lack of coor-
dination, elevated blood pressure, diarrhea, and convulsions [1].
13. Discussion and conclusion
Melatonin is considered as a potent geroprotector, anticarcinogen, and inhibitor of tumor 
growth in vivo and in vitro, and in some models it may induce tumors and promote tumor 
growth. An important mechanism of melatonin is its impact on hemopoiesis involves the 
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stimulation of melatonin on opioid receptors of bone marrow. Hence, we confirm further 
experimental studies and clinical trials which are necessary to estimate both the effectiveness 
and the safety for humans. Some antioxidants, including natural ones (e.g., α-tocopherol), 
have both geroprotector and tumorigenic potential and could be potent anticarcinogens as 
well. The results of administration of melatonin to perimenopausal women are promising. 
There are no contradictions between data on the carcinogenic and anticarcinogenic potential 
of melatonin but there are real data on the adverse effects of melatonin. Melatonin might own 
some ameliorating actions on human disorders that are contributed to the reproductive func-
tion. Such as lighting intensity during the night decreased the levels of circulating melatonin 
resulting in high risk of breast cancer [60]. Therefore, in the optimum condition, melatonin 
may have significant beneficial reproductive effects.
Epidemiological studies concerning the association between body circadian melatonin levels 
and cancer incidence led to controversial results, which were either significant association or 
no association at all. The effects of melatonin on cancers have been investigated, with a focus 
on hormone-dependent cancers. Different experimental works have suggested the ameliora-
tive effect of melatonin in numerous types of metastatic tumors, including breast, ovarian, 
prostate, oral, gastric, and colorectal cancers. The mechanisms contributed with this improve-
ment role of melatonin include various pathways of molecular origin, which are implicated 
with the activity of antioxidant enzymes, attenuation of MT1 and MT2 melatonin receptors, 
apoptosis regulation, metabolism of tumor, angiogenesis inhibition, invasion and metasta-
sis, and initiation of epigenetic alteration. In different clinical trials, melatonin exhibited the 
capability to augment the treatment effect of chemotherapeutic drugs, and might help in 
enhancing the cancer patient’s life quality. Collectively, melatonin is considered a promising 
hormone for cancers prevention and treatment. So, it could be concluded that extensive future 
work may be occur which involves the effect of melatonin on autophagy and mitophagy, 
other mechanisms of molecular origin implicated in its anticancer effect. Melatonin improves 
also chemotherapeutic drugs, which should be further determined on a large scale of drugs. 
The oncostatic effects of melatonin on some type of cancers, dosage and safety of long-term 
supplementation of melatonin must be also further elucidated.
Conflict of interest
The authors declared no conflict of interest.
Author details
Hanan Farouk Aly* and Maha Zaki Rizk
*Address all correspondence to: hanan_abdallah@yahoo.com
Therapeutic Chemistry Department, National Research Centre, Giza-Dokki, Egypt
Melatonin - Molecular Biology, Clinical and Pharmaceutical Approaches98
References
[1] Available from: http://www.Vitamins and Health
[2] Bartsch H, Buchberger A, Franz H, Bartsch C, Maidonis I, Mecke D, Bayer E. Effect of 
melatonin and pineal extracts on human ovarian and mammary tumor cells in a chemo-
sensitivity assay. Life Sciences. 2000;67:2953-2960
[3] Lissoni P, Barni S, Mandala M, Ardizzoia A, Paolorossi F, Vaghi M, Longarini R, Malugani 
F, Tancini G. Decreased toxicity and increased efficacy of cancer chemotherapy using the 
pineal hormone melatonin in metastatic solid tumor patients with poor clinical status. 
European Journal of Cancer. 1999;35:1688-1692
[4] Di Bella G, Mascia F, Gualano L, Di Bella L. Melatonin anticancer effects: Review. 
International Journal of Molecular Sciences. 2013;14:2410-2430. DOI: 10.3390/ijms14022410
[5] Lissoni P, Bolis S, Brivio F, Fumagalli L. A phase II study of neuroimmunotherapy with 
subcutaneous low-dose IL-2 plus the pineal hormone melatonin in untreatable advanced 
hematologic malignancies. Anticancer Research. 2000;20:2103-2105
[6] Eck-Enriquez K, Kiefer TL, Spriggs LL, Hill SM. Pathways through which a regimen 
of melatonin and retinoic acid induces apoptosis in MCF-7 human breast cancer cells. 
Breast Cancer Research and Treatment. 2000;61:229-239
[7] Hill SM, Blask DE, Xiang S, Yuan L, Mao L, Dauchy RT, Dauchy EM, Frasch T, Duplesis 
T. Melatonin and associated signaling pathways that control normal breast epithelium 
and breast cancer. Journal of Mammary Gland Biology and Neoplasia. 2011;16:235-245
[8] SoybIr G, Topuzlu C, Odaba SO, Dolay K, BIlIr A, Koksoy F. The effects of melatonin on 
angiogenesis and wound healing. Surgery Today. 2003;33:896-901
[9] García-Pergañeda A, Pozo D, Guerrero JM, Calvo JR. Signal transduction for melatonin 
in human lymphocytes: Involvement of a pertussis toxin-sensitive G protein. Journal of 
Immunology. 1997;159:3774-3781
[10] Dong C, Yuan L, Dai J, Lai L, Mao L, Xiang S, Rowan B, Hill SM. Melatonin inhibits 
mitogenic cross-talk between retinoic acid-related orphan receptor alpha (RORalpha) 
and ERalphain MCF-7 human breast cancer cells. Steroids. 2010;75:944-951
[11] Soto-Vega E, Meza I, Ramírez-Rodríguez G, Benitez-King G. Melatonin stimulates 
calmodulin phosphorylation by protein kinase C. Journal of Pineal Research. 2004;37: 
98-106
[12] Anisimov VN. Effects of exogenous melatonin—A review. Toxicologic Pathology. 2003; 
31:589-603
[13] Freedman DA, Zeizel H. From mouse—To man: The quantitative assessment of cancer 
risks. Statistical Science. 1988;3:3-56
Melatonin and Its Indisputable Effects on the Health State
http://dx.doi.org/10.5772/intechopen.79817
99
[14] Warner HR, Ingram D, Miller RA, Nadon NL, Richardson AG. Program for testing bio-
logical interventions to promote healthy aging. Mechanisms of Ageing and Development. 
2000;55:199-208
[15] Deerberg F, Bartsch C, Pohlmeyer G, Bartsch H. Effect of melatonin and physiological 
epiphysectomy on the developmet of spontaneous endometrial carcinoma in BDII/HAN 
rats. Cancer Biotherapy and Radiopharmaceuticals. 1997;12:420
[16] Anisimov VN. Melatonin and colon carcinogenesis. In: Bartsch C, Bartsch H, Blask DE, 
Cardinali DP, Hrushesky WJM, Mecke D, editors. The Pineal Gland and Cancer. Neuro-
immunoendocrine Mechanisms in Malignancy. Berlin: Springer; 2001. pp. 240-258
[17] Imaida K, Hagiwara A, Yoshino H, Tamano S, Sano M, Futakuchi M, Ogawa K, Asamoto 
M, Shirai T. Inhibitory effects of low doses of melatonin on induction of preneoplastic 
liver lesions in a medium-term liver bioassay in F344 rats: Relation to the influence of 
electromagnetic near field exposure. Cancer Letters. 2000;155:105-114
[18] Lissoni P. Is there a role for melatonin in supportive care? Supportive Care in Cancer. 
2002;10:110-116
[19] Bellipanni G, Bianchi P, Pierpaoli W, Bulian D, Ilyia E. Effects of melatonin in peri-
menopausal and menopausal women: A randomized and placebo controlled study. 
Experimental Gerontology. 2001;36:297-310
[20] Park SY, Jang WJ, Yi EY, Jang JY, Jung Y, Jeong JW, Kim YJ. Melatonin suppresses tumor 
angiogenesis by inhibiting HIF-1alpha stabilization under hypoxia. Journal of Pineal 
Research. 2010;48:178-184
[21] Kleszczynski K, Fischer TW. Melatonin and human skin aging. Dermato-Endocrinology. 
2012;4(3):245-252
[22] Ryoo YW, Suh SI, Mun KC, Kim BC, Lee KS. The effects of the melatonin on ultraviolet-
B irradiated cultured dermal fibroblasts. Journal of Dermatological Science. 2001;27: 
162-169. DOI: 10.1016/ S0923-1811(01)00133-5
[23] Fischer TW, Zmijewski MA, Wortsman J, Slominski A. Melatonin maintains mitochon-
drial membrane potential and attenuates activation of initiator (casp-9) and effector cas-
pases (casp-3/casp-7) and PARP in UVR-exposed HaCaT keratinocytes. Journal of Pineal 
Research. 2008;44:397-407. DOI: 10.1111/j.1600-079X.2007.00542.x
[24] Mao LL, Dauchy RT, Blask DE, Slakey LM, Xiang SL, Yuan L, Dauchy EM, Shan B, 
Brainard GC, Hanifin JP, Frasch T, Duplessis TT, Hill SM. Circadian gating of epithelial-
to-mesenchymal transition in breast cancer cells via melatonin-regulation of GSK3. 
Molecular Endocrinology. 2012;26:1808-1820
[25] Kassayova M, Bobrov N, Strojny L, Orendas P, Demeckova V, Jendzelovsky R, Kubatka 
P, Kiskova T, Kruzliak P, Adamkov M, Bomba A, Fedorocko P. Anticancer and immu-
nomodulatory effects of lactobacillus plantarum LS/07, inulin and melatonin in NMU-
induced rat model of breast cancer. Anticancer Research. 2016;36:2719-2728
Melatonin - Molecular Biology, Clinical and Pharmaceutical Approaches100
[26] Li Y, Li S, Zhou Y, X M, Zhang JJ, Xu DP, Li HB. Melatonin for the prevention and treat-
ment of cancer. Oncotarget. 2017;8:39896-39921
[27] Cutando A, Lopez-Valverde A, Arias-Santiago S, De Vicente J, De Diego RG. Role of 
melatonin in cancer treatment. Anticancer Research. 2012;32:2747-2753
[28] Srinivasan V, Spence DW, Pandi-Perumal SR, Trakht I, Cardinali DP. Therapeutic actions 
of melatonin in cancer: Possible mechanisms. Integrative Cancer Therapies. 2008;7: 
189-203
[29] Deming SL, Lu W, Beeghly-Fadiel A, Zheng Y, Cai QY, Long JR, Shu XO, Gao YT, Zheng 
W. Melatonin pathway genes and breast cancer risk among Chinese women. Breast 
Cancer Research and Treatment. 2012;132:693-699
[30] Abd El Moneim NA, El Masry H, Sorial MM. A molecular case-control study on the asso-
ciation of melatonin hormone and rs#10830963 single nucleotide polymorphism in its 
receptor MTNR1B gene with breast cancer. Middle East Journal of Cancer. 2015;6:11-20
[31] Basler M, Jetter A, Fink D, Seifert B, Kullak-Ublick GA, Trojan A. Urinary excretion of 
melatonin and association with breast cancer: Meta-analysis and review of the literature. 
Breast Care. 2014;9:182-187
[32] Sturgeon SR, Doherty A, Reeves KW, Bigelow C, Stanczyk FZ, Ockene JK, Liu S, Manson 
JE, Neuhouser ML. Urinary levels of melatonin and risk of postmenopausal breast can-
cer: Women’s health initiative observational cohort. Cancer Epidemiology Biomarkers 
& Prevention. 2014;23:629-637
[33] Brown SB, Hankinson SE, Eliassen AH, Reeves KW, Qian J, Arcaro KF, Wegrzyn LR, 
Willett WC, Schernhammer ES. Urinary melatonin concentration and the risk of breast 
cancer in nurses’ health study II. American Journal of Epidemiology. 2015;181:155-162
[34] Wang XS, Tipper S, Appleby PN, Allen NE, Key TJ, Travis RC. First-morning uri-
nary melatonin and breast cancer risk in the Guernsey study. American Journal of 
Epidemiology. 2014;179:584-593
[35] Zhao M, Wan JY, Zeng K, Tong M, Lee AC, Ding JX, Chen Q. The reduction in circulating 
melatonin level may contribute to the pathogenesis of ovarian cancer: A retrospective 
study. Journal of Cancer. 2016;7:831-836
[36] Cos S, Martinez-Campa C, Mediavilla MD, Sanchez- Barcelo EJ. Melatonin modulates 
aromatase activity in MCF-7 human breast cancer cells. Journal of Pineal Research. 
2005;38:136-142
[37] Lai L, Yuan L, Cheng Q, Dong CM, Mao LL, Hill SM. Alteration of the MT1 melatonin 
receptor gene and its expression in primary human breast tumors and breast cancer cell 
lines. Breast Cancer Research and Treatment. 2009;118:293-305
[38] Jardim-Perassi BV, Lourenco MR, Doho GM, Grigolo IH, Gelaleti GB, Ferreira LC, Borin 
TF, Moschetta MG, Zuccari D. Melatonin regulates angiogenic factors under hypoxia 
in breast cancer cell lines. Anti-Cancer Agents in Medicinal Chemistry. 2016;16:347-358
Melatonin and Its Indisputable Effects on the Health State
http://dx.doi.org/10.5772/intechopen.79817
101
[39] Jablonska K, Pula B, Zemla A, Kobierzycki C, Kedzia W, Nowak-Markwitz E, Spaczynski 
M, Zabel M, Podhorska-Okolow M, Dziegiel P. Expression of the MT1 melatonin receptor 
in ovarian cancer cells. International Journal of Molecular Sciences. 2014;15:23074-23089
[40] Koshiyama M, Matsumura N, Konishi I. Recent concepts of ovarian carcinogenesis: 
Type I and type II. BioMed Research International. 2014;2014:1-11
[41] Scarinci IC, Garcia FAR, Kobetz E, Partridge EE, Brandt HM, Bell MC, Dignan M, Ma GX, 
Daye JL, Castle PE. Cervical cancer prevention. Cancer. 2010;116:2531-2542
[42] Ciortea R, Costin N, Braicu I, Haragas D, Hudacsko A, Bondor C, Mihu D, Mihu 
CM. Effect of melatonin on intra-abdominal fat in correlation with endometrial prolif-
eration in ovariectomized rats. Anticancer Research. 2011;31:2637-2643
[43] Goncalves ND, Rodrigues RV, Jardim-Perassi BV, Moschetta MG, Lopes JR, Colombo J, 
Zuccari D. Molecular markers of angiogenesis and metastasis in lines of oral carci-
noma after treatment with melatonin. Anti-Cancer Agents in Medicinal Chemistry. 
2014;14:1302-1311
[44] Zhou Y, Li Y, Zhou T, Zheng J, Li S, Li H. Dietary natural products for prevention and 
treatment of liver cancer. Nutrients. 2016;8:156
[45] Kapitanov T, Neumann UP, Schmeding M. Hepatocellular carcinoma in liver cirrho-
sis: Surgical resection versus transarterial chemoembolization—A meta-analysis. Gas-
troenterology Research and Practice. 2015;2015:1-8
[46] Verma D, Hashim OH, Jayapalan JJ, Subramanian P. Effect of melatonin on antioxidant 
status and circadian activity rhythm during hepatocarcinogenesis in mice. Journal of 
Cancer Research and Therapeutics. 2014;10:1040-1044
[47] Moreira AJ, Ordonez R, Cerski CT, Picada JN, Garcia-Palomo A, Marroni NP, Mauriz JL, 
Gonzalez-Gallego J. Melatonin activates endoplasmic reticulum stress and apoptosis 
in rats with diethylnitrosamine-induced hepatocarcinogenesis. PLoS One. 2015;10: 
e014451712
[48] Leja-Szpak A, Jaworek J, Pierzchalski P, Reiter RJ. Melatonin induces pro-apoptotic 
signaling pathway in human pancreatic carcinoma cells (PANC-1). Journal of Pineal 
Research. 2010;49:248-255
[49] Talar-Wojnarowska R, Malecka-Panas E. Molecular pathogenesis of pancreatic adenocar-
cinoma: Potential clinical implications. Medical Science Monitor. 2006;12:RA186-RA193
[50] Menendez-Pelaez A, Rodriguez C, Dominguez D. 5-Aminolevulinate synthase mRNA 
levels in the Harderian gland of Syrian hamsters: Correlation with porphyrin concen-
trations and regulation by androgens and melatonin. Molecular and Cellular Endo-
crinology. 1991;80:177-182
[51] Bothorel B, Barassin S, Saboureau M, Perreau S, Vivien-Roels B, Malan A, Pevet P. In 
the rat, exogenous melatonin increases the amplitude of pineal melatonin secretion by a 
direct action on the circadian clock. European Journal of Neuroscience. 2002;16:1090-1098
Melatonin - Molecular Biology, Clinical and Pharmaceutical Approaches102
[52] Baturin DA, Alimova IA, Anisimov VN, Popovich IG, Zabezhinski MA, Provinciali M, 
Mancini R, Franceschi C. The effect of light regimen and melatonin on the development 
of spontaneous mammary tumors in HER-2/neu transgenic mice is related to a down 
regulation of HER-2/neugene expression. Neuroendocrinology Letters. 2001;22:439-445
[53] Krek W. Proteolysis and the G1-S transition: The SCF connection. Current Opinion in 
Genetics & Development. 1998;8:36-42
[54] Blask DE, Sauer LA, Dauchy RT. Melatonin as a chronobiotic/ anticancer agent: Cellular, 
biochemical, and molecular mechanisms of action and their implications for circadian-
based cancer therapy. Current Topics in Medicinal Chemistry. 2002;2:113-132
[55] Hemminki A. The molecular basis and clinical aspects of Peutz-Jeghers syndrome. 
Cellular and Molecular Life Sciences. 1999;55:735-750
[56] Lund J, Tedesco P, Duke K, Wang J, Kim SK, Johnson TE. Transcriptional profile of aging 
in C. elegans. Current Biology. 2002;12:1566-1573
[57] Pletscher SD, Macdonald SJ, Marguerie R, Certa U, Stearns SC, Goldstein DB, Patridge L. 
Genome-wide transcript profiles in aging and calorically restricted Drosophila melano-
gaster. Current Biology. 2002;12:712-723
[58] Weindruch R, Kayo T, Lee CK, Prolla TA. Gene expression profiling of aging using DNA 
microarrays. Mechanisms of Ageing and Development. 2000;123:177-193
[59] Srinivasan V, Spence WD, Pandi-Perumal SR, Zakharia R, Bhatnagar KP, Brzezinski A. 
Melatonin and human reproduction: Shedding light on the darkness hormone. Gyneco-
logical Endocrinology. 2009;25:779-785
[60] Stevens RG. Circadian disruption and breast cancer: From melatonin to clock genes. 
Epidemiology. 2005;16:254-258
Melatonin and Its Indisputable Effects on the Health State
http://dx.doi.org/10.5772/intechopen.79817
103

